Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03589586 · ClinicalTrials.gov registry record · NA
Clinical Effectiveness of DermACELL AWM in Subjects With Chronic Venous Leg Ulcers
A NA study, sponsored by LifeNet Health.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03589586 is a NA study that has completed, run by LifeNet Health. The registered enrollment target is 100 participants.
The verdict
NCT03589586, a NA study, has completed, sponsored by LifeNet Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study is a multicenter, randomized, controlled, open-label trial designed to evaluate the safety and efficacy of DermACELL in subjects with a single target chronic venous leg ulcer (VLU).
Interventions
- OTHER DermACELL AWM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-06-25 |
| Est. Completion | 2021-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03589586
The ClinicalTrials.gov registry entry for NCT03589586 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LifeNet Health, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DermACELL AWM is the first listed.
NCT03589586 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03589586 about?
NCT03589586 is a clinical study titled "Clinical Effectiveness of DermACELL AWM in Subjects With Chronic Venous Leg Ulcers". This study is a multicenter, randomized, controlled, open-label trial designed to evaluate the safety and efficacy of DermACELL in subjects with a single target chronic venous leg ulcer (VLU).
What is the current status of trial NCT03589586?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2018-06-25. Estimated completion is 2021-03-15.
What interventions are being tested in trial NCT03589586?
The interventions under investigation include: DermACELL AWM (OTHER).
Who is sponsoring clinical trial NCT03589586?
This trial is sponsored by LifeNet Health, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.